EUVIMEDOpdag EUVIMED
Video/Audio

Network Pharmacology and Rat Caudal-disc Puncture Validation of Yi Qi Huo Xue Decoction For Lumbar Disc Degeneration

Yuan Chai, Zixin Wang, Xuyu Shen, Zhiqiang Wang, Yongyuan Li, Yuan Xu, Yuxiang Dai, Shun Lin, Yukai Lu, Yifu Sun, Xiaoyun Zhang, Jingtao Liu

Journal of Visualized Experiments · 2026

DOI: 10.3791/71410 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Yuan Chai and 11 co-authors. Institution: Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Ruikang Hospital Affiliated with Gu…. Major MEDLINE topics: Intervertebral Disc Degeneration, Drugs, Chinese Herbal, Network Pharmacology, Lumbar Vertebrae. 85 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In this study, network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation were used to investigate the pharmacological basis and potential molecular mechanisms of Yi Qi Huo Xue Decoction (YQHXD) in lumbar disc degeneration (LDD). A total of 678 active compound-related targets of YQHXD and 296 potential LDD-associated therapeutic targets were identified. Protein-protein interaction network analysis and topological analysis identified several candidate targets, including AKT1, IL6, TNF, BCL2, and STAT3. Enrichment analyses using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes indicated that the candidate targets were linked to functions including protein binding and ATP binding, with pathway enrichment that included PI3K-AKT signaling. Molecular docking predicted interactions between selected active compounds, such as quercetin, Tetraneurin A, and isorhamnetin, and the core targets. Molecular dynamics simulations further suggested that the lowest-energy complexes remained stable. Seventy male Sprague-Dawley rats were randomly assigned to the control, sham-operated, model, positive control, and low-, medium-, and high-dose YQHXD groups. After the establishment of a coccygeal intervertebral disc puncture model in the model, positive control, and YQHXD groups, rats were administered YQHXD or celecoxib by oral gavage for 8 weeks, whereas the control and sham-operated groups received normal saline. Histopathological evaluation showed that YQHXD treatment was associated with reduced intervertebral disc degeneration in this model. Enzyme-linked immunosorbent assay, polymerase chain reaction, and western blot analyses showed changes in the mRNA and protein expression levels of selected targets, including AKT1, BCL2, and STAT3. These findings suggest that YQHXD may exert preclinical protective effects in LDD through multi-component and multi-target regulation involving inflammation- and apoptosis-related mechanisms. This study provides preliminary preclinical evidence supporting further investigation of YQHXD for LDD.

Subjects

MeSH terms (MEDLINE)

Intervertebral Disc DegenerationDrugs, Chinese HerbalNetwork PharmacologyLumbar VertebraeAnimalsMaleRats, Sprague-DawleyRatsMolecular Docking SimulationMolecular Dynamics Simulation

Substances

Drugs, Chinese Herbal

Authors and institutions

  • Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Ruikang Hospital Affiliated with Guangxi University of Chinese Medicine.
  • Ruikang Hospital Affiliated with Guangxi University of Chinese Medicine.
  • Guangxi University of Chinese Medicine.
  • Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Suzhou Academy of Wumen Chinese Medicine.
  • Ruikang Hospital Affiliated with Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine.
  • Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Suzhou Academy of Wumen Chinese Medicine; okdoctor@163.com.

Cite

APA

Chai, Y., Wang, Z., Shen, X., Wang, Z., Li, Y., Xu, Y., Dai, Y., Lin, S., Lu, Y., Sun, Y., Zhang, X., & Liu, J. (2026). Network Pharmacology and Rat Caudal-disc Puncture Validation of Yi Qi Huo Xue Decoction For Lumbar Disc Degeneration. Journal of Visualized Experiments. https://doi.org/10.3791/71410

Vancouver

Chai Y, Wang Z, Shen X, Wang Z, Li Y, Xu Y, et al. Network Pharmacology and Rat Caudal-disc Puncture Validation of Yi Qi Huo Xue Decoction For Lumbar Disc Degeneration. Journal of Visualized Experiments. 2026. doi:10.3791/71410

BibTeX
@article{Chai2026,
  author = {Chai, Yuan and Wang, Zixin and Shen, Xuyu and Wang, Zhiqiang and Li, Yongyuan and Xu, Yuan and Dai, Yuxiang and Lin, Shun and Lu, Yukai and Sun, Yifu and Zhang, Xiaoyun and Liu, Jingtao},
  title = {Network Pharmacology and Rat Caudal-disc Puncture Validation of Yi Qi Huo Xue Decoction For Lumbar Disc Degeneration},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/71410}
}
Start for free →